ANNAPOLIS, Md., Oct. 23 /PRNewswire-FirstCall/ -- PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that David P. Wright, President and Chief Executive Officer of PharmAthene, will present at the 7th Annual BIO Investor Forum in San Francisco on Thursday, October 30, 2008 at 11:00 a.m. Pacific Time.
PharmAthene's presentation will be available via webcast on the company's website at www.pharmathene.com. To access the webcast go to the Investor Relations page and click on the links News & Events / Calendar of Events / PharmAthene at 7th Annual BIO Investor Forum. For assistance contact Stacey Jurchison at 410-269-2610.
About PharmAthene, Inc.
PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead product development programs include:
For more information about PharmAthene, please visit www.PharmAthene.com.
CONTACT: Stacey Jurchison, Director, Corporate Communications of
PharmAthene, Inc., +1-410-269-2610, Cell +1-410-474-8200,
JurchisonS@PharmAthene.com
Web site: http://www.pharmathene.com/
